CAS No. |
82993-43-9 |
|---|---|
中文名称 |
N-((2R,3R,4R,5R)-4-(((2S,3R,4S,5R,6R)-4,5-二羟基-6-(羟甲基)-3-(((2S,3S,4R,5S,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)-5,6-二羟基-1-氧代-3-(((2S,3S,4R,5S,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)己烷-2-基)乙酰胺 |
英文名称 |
N-((2R,3R,4R,5R)-4-(((2S,3R,4S,5R,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5,6-dihydroxy-1-oxo-3-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexan-2-yl)acetamide |
别名 |
PWKOEMUICVNKKC-UHFFFAOYSA-I;2-AcetaMido-2-deoxy-3-O-(α-L-fucopyranosyl)-4-O-[2-O-(α-L-fucopyranosyl)-b-D-galactopyranosyl]-D-glucopyranoside, Fuc1-α-2Gal1-b-4[Fuc1-α-3]GlcNAc;LewisY (LeY) tetraose;Fucα1-2Galβ1-4(Fucα1-3)GlcNAc;2-Acetamido-2-deoxy-3-O-(a-L-fucopyranosyl)-4-O-[2-O-(a-L-fucopyranosyl)-b-D-galactopyranosyl]-D-glucopyranoside;D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[O-6-deoxy-α-L-galactopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)]-2-(acetylamino)-2-deoxy-;Lewis Y (LeY) tetraose (>90% NMR);Lewis Y Tetrasaccharide/Fucα1, 2Galβ1, 4 (Fucα1, 3)GlcNAc |
标准英文名 |
N-((2R,3R,4R,5R)-4-(((2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5,6-dihydroxy-1-oxo-3-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)hexan-2-yl)acetamide |
MDL No. |
MFCD00797615 |
分子式 |
C26H45NO19 |
分子量 |
675.63 |
精确分子量 |
675.26 |
SMILES |
C[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O[C@H]([C@H](C=O)NC(C)=O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O[C@@H]3O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]3O)[C@H](O)CO)O1 |
标准SMILES |
C[C@@H]1O[C@@H](O[C@@H]([C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@H](O)CO)[C@H](C=O)NC(C)=O)[C@@H](O)[C@H](O)[C@@H]1O |
用途 |
Lewis Y tetrasaccharide is an antigen associated with metastasis and poor prognosis in malignant ovarian cancer. |
InChIKey |
APQKPNYMOAYHPL-ILVDQUQFSA-N |
|
|
评论 |
|---|